Европейский союз - словенский - EMA (European Medicines Agency)

instituto grifols s.a. - fostamatinib disodium - trombocitopenija - drugi sistemski hemostatics - tavlesse je indiciran za zdravljenje kronične imunska trombocitopenija (itp) pri odraslih bolnikih, ki so utrjene za druge oblike zdravljenja.

Европейский союз - словенский - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Европейский союз - словенский - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).

Европейский союз - словенский - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - zdravila, ki se uporabljajo pri diabetesu - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 in 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure.  chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.

Европейский союз - словенский - EMA (European Medicines Agency)

novo nordisk a/s - insulin aspart - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - zdravljenje diabetes mellitus.

Европейский союз - словенский - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).

Словения - словенский - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

teva b.v. - sitagliptin - filmsko obložena tableta - sitagliptin 50 mg / 1 tableta - sitagliptin

Словения - словенский - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

teva b.v. - sitagliptin - filmsko obložena tableta - sitagliptin 100 mg / 1 tableta - sitagliptin

Словения - словенский - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

teva b.v. - sitagliptin - filmsko obložena tableta - sitagliptin 25 mg / 1 tableta - sitagliptin

Словения - словенский - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sitagliptin - filmsko obložena tableta - sitagliptin 100 mg / 1 tableta - sitagliptin